Antithrombotic treatment in atrial fibrillation.
Postgrad Med J
; 84(991): 252-8, 2008 May.
Article
en En
| MEDLINE
| ID: mdl-18508982
Atrial fibrillation (AF) can significantly increase morbidity and mortality. It is gaining in clinical and economic importance, being the most commonly encountered tachyarrhythmia in clinical practice. Stroke is the most serious complication. Evidence from AF antithrombotic treatment trials is reviewed, risk stratification of patients with AF is discussed, and recommendations for anticoagulation are presented.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
2_ODS3
/
6_ODS3_enfermedades_notrasmisibles
Problema de salud:
2_muertes_prematuras_enfermedades_notrasmisibles
/
6_cardiovascular_diseases
/
6_cerebrovascular_disease
Asunto principal:
Fibrilación Atrial
/
Warfarina
/
Inhibidores de Agregación Plaquetaria
/
Aspirina
/
Fibrinolíticos
/
Anticoagulantes
Tipo de estudio:
Etiology_studies
/
Guideline
Límite:
Humans
Idioma:
En
Revista:
Postgrad Med J
Año:
2008
Tipo del documento:
Article
